Medications
Advanced ovarian cancer treatment approved
A targeted treatment for advanced ovarian cancer has been approved for use on the NHS in England and will be paid for by the Cancer Drugs Fund.
Oct 14, 2019
0
3
A targeted treatment for advanced ovarian cancer has been approved for use on the NHS in England and will be paid for by the Cancer Drugs Fund.
Oct 14, 2019
0
3
Brigatinib is a next-generation ALK inhibitor that earned FDA approval in 2017 as a second-line therapy after treatment with crizotinib for ALK-positive non-small cell lung cancer. Recently, clinical trial results published ...
May 21, 2019
0
7
A team of researchers from Boston University School of Medicine (BUSM) and Boston Medical Center (BMC), report that primary care providers (PCP) fail to report a substantial number of cases of child maltreatment. The study, ...
Nov 9, 2011
0
0